Qi Deng

15PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersHaematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 21, 2026
Exploring CAR-T Resistance Mechanisms in Relapsed/Refractory DLBCL via Integrated Histopathological and Transcriptomic Profiling.

|Jul 30, 2026
Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR-T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages.

|May 28, 2026
Role of tumor microenvironment composition and metabolism in lymphoid malignancies and therapeutic strategies.

|May 25, 2026
Long-term follow-up results of anti-BCMA CAR-T cell therapy combined with autologous hematopoietic stem cell transplantation in relapsed/refractory multiple myeloma with extramedullary disease.

|Feb 10, 2026
Guided by target selection, inotuzumab ozogamicin successfully salvaged a patient with refractory follicular lymphoma after anti-CD19 and anti-CD22 CAR T-cell therapy: a case report and literature review.

Xin Li, Shuquan Gao, Rui Cui

|Sep 22, 2025
COVID-19 Infection Confirmed by Bronchoalveolar Lavage Fluid Metagenomics -Next-Generation Sequencing Instead of Pharyngeal Swabs in Follicular Lymphoma: Three-Case Report and Literature Review.

Can Liu, Yupeng Song, Siyan Niu

Pageof 3

Frequent Collaborators

4 joint publications

Qing Li

4 joint publications

Rui Cui

3 joint publications

Jia Wang

3 joint publications

Juan Mu